• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSZ2500010 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products License Renew 2025-05-12 Lilly France;Eli Lilly Nederland BV;Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2400163 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2024-06-25 Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd view
JYSZ2400014 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products License Renew 2024-03-07 Eli Lilly Nederland BV;Eli Lilly Italia SpA;Lilly Suzhou Pharmaceutical Co Ltd view
CYSB2200275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2022-12-13 Lilly Suzhou Pharmaceutical Co Ltd view
CXSS2200070 精蛋白锌赖脯胰岛素混合注射液(25R) Injection Biological Products(3.3) New Drug Application 2022-08-01 Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd view
JYSB2101191 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-12-10 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2101190 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-12-10 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2101192 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-12-10 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2101124 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-09-13 Lilly France;Eli Lilly Nederland BV view
CYSB2101162 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-08-20 Gan & Lee Pharmaceuticals view
JYSB2101017 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-04-30 Lilly France;Eli Lilly Nederland BV view
JYSB2101016 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-04-30 Eli Lilly Nederland BV;Eli Lilly Italia SpA view
JYSB2101018 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-04-30 Lilly France;Eli Lilly Nederland BV view
CYSB2100032 精蛋白锌赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2021-01-16 甘李药业股份有限公司 Gan & Lee Pharmaceuticals Certificate Issued 2021-08-17 view
JYSB2000551 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-10-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV Certificate Issued 2020-12-07 view
JYSB2000550 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-10-29 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA Certificate Issued 2020-12-07 view
JYSB2000464 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA Filed 2020-09-29 view
JYSB2000465 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-09-17 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Lilly France;Eli Lilly Nederland BV Filed 2020-09-29 view
CYSB2000182 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-07-04 甘李药业股份有限公司 Gan & Lee Pharmaceuticals Certificate Issued 2020-12-21 view
JYSB2000275 精蛋白锌重组赖脯胰岛素混合注射液(25R) Injection Biological Products Supplementary Application 2020-06-18 礼来苏州制药有限公司 Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly Nederland BV;Eli Lilly Italia SpA Filed 2020-06-22 view